COVID-19 Drug Remdesivir Could Cost Up to $3,120 Per Patient, Maker Says

MONDAY, June 29, 2020 — The maker of remdesivir, the first drug that showed promise in treating coronavirus infections, will charge U.S. hospitals $3,120 for a patient with private insurance, the drug company announced Monday.
Because of how the…
Source: Topamax